Bio-Rad Laboratories Inc. (BIO) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $359.49 -0.72%
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net income per share diluted attributable to Bio-Rad: 0.61
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q1 EPS of $1.09, $0.02 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $486.3 million versus the consensus estimate of $492.35 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
